Evidence map›Paper›PMID 30301205›Full record

ReviewMolecules (Basel, Switzerland)2018

Intestinal Saturated Long-Chain Fatty Acid, Glucose and Fructose Transporters and Their Inhibition by Natural Plant Extracts in Caco-2 Cells.

Katharina Schreck, Matthias F Melzig

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. A NovelMicroorganisms · 2025
    Article
  3. Article
  4. Article
  5. Antihyperglycemic effects ofPharmaceutical biology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Antimicrobial, Antioxidant, and Cytotoxic Activities ofAntibiotics (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Antioxidants (Basel, Switzerland) · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katharina SchreckFreie Universitaet Berlin, Institute of Pharmacy-Pharmaceutical Biology, Koenigin-Luise-Str. 2+4, D-14195 Berlin, Germany. kschreck@zedat.fu-berlin.de.ORCID 0000-0003-2649-8997
Matthias F MelzigFreie Universitaet Berlin, Institute of Pharmacy-Pharmaceutical Biology, Koenigin-Luise-Str. 2+4, D-14195 Berlin, Germany. melzig@zedat.fu-berlin.de.
Freie Universität Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal absorption of fatty acids, glucose and fructose is part of the basic requirements for the provision of energy in the body. High access of saturated longchain fatty acids (LCFA), glucose and fructose can facilitate the development of metabolic diseases, particularly the metabolic syndrome and type-2 diabetes mellitus (T2DM). Research has been done to find substances which decelerate or inhibit intestinal resorption of these specific food components. Promising targets are the inhibition of intestinal long-chain fatty acid (FATP2, FATP4), glucose (SGLT1, GLUT2) and fructose (GLUT2, GLUT5) transporters by plant extracts and by pure substances. The largest part of active components in plant extracts belongs to the group of polyphenols. This review summarizes the knowledge about binding sites of named transporters and lists the plant extracts which were tested in Caco-2 cells regarding uptake inhibition.

Indexed as

AnimalsCaco-2 CellsDiabetes Mellitus, Type 2Fatty AcidsFructoseGlucoseHumansIntestinal AbsorptionIntestinesMonosaccharide Transport ProteinsPlant ExtractsPolyphenolsFatty AcidsFructoseGlucoseMonosaccharide Transport ProteinsPlant ExtractsPolyphenolsCaco-2 cellsdiabetesFATP2FATP4GLUT2GLUT5intestinal transportersplant extractsSGLT1uptake inhibition

Identifiers

PMID30301205
PMCPMC6222386
OpenAlexW2895330895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.